Payer Support For Express Scripts’ “Transition” From Walgreens Shows Depth Of Interest In Drug Benefit Savings, PBM Says
This article was originally published in The Pink Sheet Daily
During Express Scripts’ earnings call Feb. 23, CEO George Paz said the pharmacy benefit manager’s clients are willing to tolerate the potential inconvenience of a smaller pharmacy network, without Walgreens, because it can save them real money.
You may also be interested in...
The contracting dispute between the drug chain and PBM may also presage tougher negotiations ahead for biopharmaceutical companies, particularly if Express Scripts is successful in its bid to acquire rival PBM Medco.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.